Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction
- 1 October 2016
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 347 (2) , 322-331
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology (105–2314-B-030–005)
- Fu Jen Catholic University (A0104020, A0204104)
- Terry Whole Brain & Potential Development Center (105–11-01)
This publication has 84 references indexed in Scilit:
- Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructoseThe Journal of Nutritional Biochemistry, 2011
- AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespanJournal of Molecular Medicine, 2011
- Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREBNature, 2011
- AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathiesActa Neuropathologica, 2010
- AMP-activated protein kinase and its downstream transcriptional pathwaysCellular and Molecular Life Sciences, 2010
- Mitochondrial medicine for neurodegenerative diseasesThe International Journal of Biochemistry & Cell Biology, 2010
- The Alzheimer's disease mitochondrial cascade hypothesis: An updateExperimental Neurology, 2009
- Different Patterns of Cerebral Injury in Dementia With or Without DiabetesArchives of Neurology, 2009
- Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's diseaseNature Medicine, 2008
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's diseaseTrends in Molecular Medicine, 2008